aztreonam has been researched along with Arthritides, Bacterial in 6 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multicenter trials were conducted to determine the safety and efficacy of aztreonam in the treatment of patients with gram-negative bacterial infections." | 5.05 | Aztreonam: worldwide overview of the treatment of patients with gram-negative infections. ( Bendush, CB; Henry, SA, 1985) |
| " Dosage of aztreonam was 2 to 8 g per day administered intravenously or intramuscularly for five to 52 days." | 2.66 | Aztreonam in the treatment of serious orthopedic infections. ( Beskin, J; Beville, R; Haddad, RJ; Holmes, B; Mogabgab, WJ; Pollock, B; Pribyl, C; Salzer, R, 1985) |
| "Aztreonam is a novel antimicrobial agent belonging to the monobactam class of antibiotics." | 1.27 | Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1985) |
| "Aztreonam was well tolerated." | 1.27 | Treatment of gram-negative infections with aztreonam. ( Lee, TJ; Simons, WJ, 1985) |
| "Aztreonam is a monocyclic beta-lactam antibiotic that inhibits aerobic gram-negative bacilli, including beta-lactamase-producing species." | 1.27 | Current state of infectious diseases--potential areas of directed therapy with aztreonam. ( Neu, HC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilahi, OA | 1 |
| Swarna, U | 1 |
| Hamill, RJ | 1 |
| Young, EJ | 1 |
| Tullos, HS | 1 |
| Pribyl, C | 1 |
| Salzer, R | 1 |
| Beskin, J | 1 |
| Haddad, RJ | 1 |
| Pollock, B | 1 |
| Beville, R | 1 |
| Holmes, B | 1 |
| Mogabgab, WJ | 1 |
| Henry, SA | 1 |
| Bendush, CB | 1 |
| Scully, BE | 1 |
| Neu, HC | 2 |
| Simons, WJ | 1 |
| Lee, TJ | 1 |
1 review available for aztreonam and Arthritides, Bacterial
| Article | Year |
|---|---|
Concomitant crystal and septic arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Gouty; Arthritis, Infectious; Aztreonam; Escherichia coli | 1996 |
2 trials available for aztreonam and Arthritides, Bacterial
| Article | Year |
|---|---|
Aztreonam in the treatment of serious orthopedic infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clinical | 1985 |
Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clini | 1985 |
3 other studies available for aztreonam and Arthritides, Bacterial
| Article | Year |
|---|---|
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infectio | 1985 |
Treatment of gram-negative infections with aztreonam.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; | 1985 |
Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Topics: Abdomen; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Biliary Trac | 1985 |